Search

Share on

Multivitamin Suckable Tablet formulation for direct compression

Published January 27, 2026

Resource Pharma

Directly compressible formulation of multivitamin suckable tablets using NEOSORB® P 300 C sorbitol as filler-binder

tablet.jpg

Objective

Develop a prototype formulation for a suckable multivitamin tablet demonstrating the excellent tabletability of NEOSORB® P 300 C as a filler-binder for direct compression of tablets with high hardness.

Formula

IngredientFunctionality of the ingredientmg/tablet
(total weight: 500 mg)
% by weight
Vitamin A (retinol acetate)Active ingredient3.00 (5000 IU)0.600
Vitamin D2 (ergocalciferol)Active ingredient0.01 (400 IU)0.002
Vitamin E (DL.α.tocopherol acetate)Active ingredient1.34 (2 IU)0.268
Vitamin C (L(+) ascorbic acid)Active ingredient60.0012.000
Vitamin PP (nicotinamide)Active ingredient10.002.000
Vitamin B2 (riboflavine)Active ingredient1.500.300
Vitamin B1 (thiamin mononitrate)Active ingredient1.200.240
Vitamin B6 (pyridoxine hydrochloride)Active ingredient1.200.240
Vitamin H (D(+) Biotin)Active ingredient0.040.008
Vitamin B12 (cyanocobalamin)Active ingredient0.030.006
Orange powder flavorFlavor5.001.000
NEOSORB® P 300 C sorbitolDirect compression filler-binder411.2882.256
SilicaGlidant1.500.300
Sodium saccharinateSweetener0.400.080
Magnesium stearateLubricant3.50.700

Method

1. Solubilize the vitamins A, B12, D2 and E in a sufficient amount of ethanol.
2. Spray the solution on the NEOSORB® P 300 C sorbitol using a fluidized air bed dryer.
3. Evaporate the solvent.
4. In a mixer, mix all the ingredients except the magnesium stearate for 20 minutes.
5. Add the magnesium stearate and mix for 5 minutes more.
6. Compress the powder with a 13 mm diameter round flat punch.

Additional comments

Tablet hardness

103 N

Tablet density

1.394 g/cm3

Tablet thickness

2.7 mm

Tablet mass

500 mg

Comment on Roquette product benefits

NEOSORB® sorbitol provides key functional properties of a filler and filler/binder as well as a bulk sweetener. Our sorbitol range has excellent tableting properties, as well as being non-cariogenic, non-acidogenic and sugar-free. These properties make it suitable to be used in formulation of several oral dosage forms including suckable tablets or lozenges.
NEOSORB® is EP/USP-NF/JP compliant (varies by grade).

® Registered trademark(s) of Roquette Frères. 
 

Disclaimer

This formula is a guideline for recommended use of our products; it does not imply consent to their use in violation of existing patent(s). 
These details are for information only, and we believe them to be reliable.